Legal issues related to the medicinal use
of propolis and other bee products in Europe, in contrast with other continents,
including North and South America
(paper presented during the international Apitherapy Symposium organized by
Nippon Apitherapy Society in Japan,
June 2006)
Situation in
Propolis tincture, Miprosept (propolis
suppositories) and Propolis Spray (against burns and skin lesions) are
considered medicinal remedies, because they have a clear medicinal destination,
being used against clearly stated diseases.
“Apireven” (bee venom) cream + “Propoderm”
creams are considered cosmetically products because their destination is skin
care.
In
Situation in
Pharma Nectar
(President Jose Alejandre Abreu) released recently (June 05, 2006) through our
E-mail Discussion List (“Apitherapy-List) the following announcement:
Propolis (raw and extract), bee pollen, royal jelly
and honey was regulated in
However, after a great pressure from apitherapists,
researchers and pharmaceutical industry, since October 2005 it
is possible to get a registration of propolis as a medicine,
under some specific requirements from Ministry of Health:
Minimum Quality Requirements:
·
Sensorial Characteristics: aspect, color
and odor;
·
Physico-chemical requirements: desiccation
loss, total dust, insoluble dust in HCI, density, viscosity and pH;
·
Figures: alcoholic grade (when applied), antioxidative
activity, chemical markers (qualitative and quantitative), total phenolics,
flavonoids, volatiles compounds, wax;
·
Undesirable Contaminants: Microbiology pathogens
including Paenibacillus larvae, coliforms, fungi east,
additives, heavy metal, pesticides, foreign matters.
·
Manufacturing process.
·
Technical reports should be issued with all the
above mentioned information.
·
Description of bee species and botanical
origin on the production site.
·
Additional tests: antimicrobial
activity (in vitro).
Safety and Efficacy Proves
Efficacy tests are not demanded for
topic use products with anti-inflammatory, anti-septic and healing
indications. For other indications different from the traditional indications and
associated with herbs extracts or any other active ingredients the manufacturer
must show the following proves:
1)
Phase III clinical trial on the therapeutic effect and
toxicological tests.
2) Safety and efficacy proves may be demonstrated by means of indexed papers as long as the data base has been originated from the specific propolis to be registered. In this case a minimum 8 papers on clinical trials and safety are demanded.
Mr. Jose Alexandre S. Abreu (Nectar Farmaceutica Ltda)
(E-mail: pharmanectar@pharmanectar.com.br
) adds:
“The "Technical Note"
just refers the products sold with some therapeutic indication; it is
not enforcement to all grades of propolis but only for products sold
as drug. Nowadays we cannot even make simple claims such as its
well known antioxidant activity. So, in theory this new regulation
will allow for an adequate room so that companies could produce and sell
propolis made drugs. If we consider this side of coin, it could be an
important and decisive step for Propotherapy. We could properly
advertise for example the chemotherapeutic effect of propolis at high
dosage and concentrations, we could define therapeutic protocols and most
important do everything legally and openly. Propotherapy and Apitherapy
would gain a lot, all chain, from the beekeepers to the patients.
What are the negative sides of this
regulation? Clinical trials, toxicological tests and a pharmaceutical grade
production plant is practically impossible to afford for a small beekeeping
industry (in
propolis. We are sure that in terms of propolis, the pharmaceutical industry
will gradually swallow the beekeeping industry.
As an intermediary remedy for this situation propolis could be registered
optionally and additionally as a functional food, which is a truth and also
allows for a set of health claims, but under the scope of food and not
medicine. This transitory grade could allow the beekeeping industries to
prepare themselves to fulfill the demanding pharmaceutical standards.
On the other hand it
seems ironic that while “PubMed” (http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
) shows 85 works on the expression "propolis and cancer"
(most conclusions of these documents suggest the chemotherapeutic or chemo-preventative
use of propolis), we insist on keeping propolis as a mere food or food
supplement...”
Situation
in
March 1999:
Propolis, bee pollen[2], and royal jelly are all
co-products of honey production that are used in dietary supplements [3]
FDA regulates dietary supplements under a different set of regulations than
those covering "conventional" foods and drug products (prescription
and Over-the-Counter). Under the Dietary Supplement Health and Education Act of
1994 (DSHEA), the dietary supplement manufacturer is responsible for
ensuring that a dietary supplement is safe before it is marketed. FDA
is responsible for taking action against any unsafe dietary supplement product
after it reaches the market. Generally, manufacturers do not need to
register their products with FDA nor get FDA approval before producing or
selling dietary supplements.* Manufacturers must make
sure that product label information is truthful and not misleading.
FDA's post-marketing responsibilities include monitoring safety, e.g. voluntary
dietary supplement adverse event reporting, and product information, such as
labeling, claims, package inserts, and accompanying literature. The Federal
Trade Commission regulates dietary supplement advertising.
Source: http://www.cfsan.fda.gov/~dms/supplmnt.html
CONCLUSION
Each company can register its products according to the
target they have: general population, in pretty good health or ill people.
When the “target” is the general population the registration
of the bee products is usually asked as FOOD SUPPLEMENTS.
When the “target” is though the ill population (including
the hospitals and pharmacies) and when on the product label is clearly written
that the indication of the product is to cure this or that disease, then the
registration must be as a MEDICINAL PRODUCT.
When the bee product is sold as a Food Supplement, on
the label are written the following kind of things:
When the bee product is sold as a Medicinal Product,
on the label are written the following kind of things:
If we analyze the whole medical and Apitherapy related literature published in the last 50 years or so, we reach the following general conclusions:
So, with the exception of bee venom and beeswax that can not be considered as foods, or food supplements, all other main bee products (honey, honeydew honey, bee pollen, bee bread, propolis, royal jelly and Apilarnil) are officially registered as:
|
Bee venom |
|
|
Honey |
|
|
Honeydew honey |
Same as above |
|
Propolis (raw) |
|
|
Propolis in various extracts (ethanol extract, mono-propilene
glycol extract, etc.) |
|
|
Beeswax |
|
|
Royal jelly |
|
|
Apilarnil |
|
|
Bee pollen and bee bread |
|
* * * * *
[1] Definition of “food
supplement” in
[2] In some documents pollen is considered as a “functional
food”.
[3] Economic Characterization of the
Dietary Supplement Industry
Final Report
Dietary supplements are made up of a
diverse group of products, so production practices differ as much as the
products themselves. Even within a particular category of DS products, there
may be many different types of production processes. However, information on
how the products are produced is necessary for characterizing the supply of DS
products. In this section, we describe the production processes for vitamins,
minerals, herbals and botanicals, amino acids, proteins, and other DS products,
as well as the final dosage forms of all DS products. Good manufacturing
practices (GMPs) and costs of manufacturing are also described briefly.
Within each DS product type are
numerous different individual substances. For example, 11 vitamins and 13
minerals have been identified as essential nutrients for humans (Clayman,
1994), but additional non-essential vitamins and minerals have been identified
as well (see Tables 2-1 and 2-2). Perhaps several hundred herbal and botanical
products have been manufactured for human consumption. In this section, we
summarize the production practices for each type of DS product for which we
were able to obtain information. In addition to the primary DS product types,
we also include information on algae, bee products, and teas.
(snip)
Bee Products
Propolis, bee pollen, and royal jelly are all co-products of honey production
that are used in dietary supplements. Propolis is a sticky substance that is
secreted by bees to seal cracks and spaces within the hive. Its antimicrobial
properties help to control the growth of bacteria and fungus within the hive.
Beekeepers can collect small quantities of propolis by hand by scraping it out
of the crevices and corners of the hive. Those who collect it commercially may
place a fine-mesh plastic screen about an inch above the hive. In the fall, the
bees attempt to seal the space between the screen and the hive with propolis.
The beekeeper later removes the screen along with the propolis. A healthy hive
can produce about 200 grams of propolis in a season.
To collect pollen from bees, beekeepers construct pollen traps. These are
screens that the bees must crawl through in order to enter the hive. As they
crawl through the mesh, about 10 percent of the pollen that they are
carrying is scraped off and falls into a clean tray below. Beekeepers can
collect 2 to 3 kg of pollen from a single hive in one season without causing a
shortage for the bees.
Royal jelly is a substance that bees produce in minute quantities to feed
larvae that are to become queen bees. It is collected by hand with either a
special spoon or a suction device. Royal jelly degrades easily and should be
refrigerated in air-tight brown glass containers.
Many beekeepers collect propolis, pollen, and royal jelly for their own
use and do not sell it commercially. Only large beekeeping operations produce
enough of these substances for commercial marketing (Schech, 1998).